Tumors of the transversus linguae muscle are abnormal growths—benign or malignant—that arise from the transverse fibers of the tongue’s intrinsic musculature. Though rare compared with tumors of other tongue regions, they can interfere with tongue shape, mobility, speech, and swallowing. These growths originate either from muscle cells (myogenic tumors), connective tissue (fibrous tumors), nerve sheath (schwannomas), vascular tissue (hemangiomas), or epithelial layers (squamous cell carcinomas). Early recognition and accurate diagnosis are essential for effective management and preservation of oral function.
Anatomy of the Transversus Linguae Muscle
Structure and Location
The transversus linguae is one of four intrinsic tongue muscles. It consists of thin, horizontal fibers that run side to side within the tongue’s body, deep to the superior longitudinal muscle. These fibers narrow and elongate the tongue when they contract, contributing to fine shape changes rather than gross movement.
Origin
The fibers emerge from the median fibrous septum, a vertical partition that divides the tongue into left and right halves. This central origin lets the muscle spread laterally across the tongue.
Insertion
The horizontal fibers fan outward and insert into the submucosal connective tissue and septum near the lateral margins. This broad insertion anchors the muscle along the tongue’s mid-third.
Blood Supply
Arterial blood reaches the transversus linguae via branches of the deep lingual artery (a terminal branch of the lingual artery). Capillaries penetrate the muscle fibers, ensuring oxygen and nutrient delivery. Venous drainage returns through the deep lingual vein into the internal jugular system.
Nerve Supply
The hypoglossal nerve (cranial nerve XII) provides motor innervation. These nerve fibers travel within the tongue’s septum before branching laterally to each intrinsic muscle.
Functions
-
Tongue Narrowing: When the transverse fibers contract, the tongue becomes thinner and longer, aiding in precise articulation.
-
Shape Modulation: Fine adjustments for consonant production (e.g., “t,” “d”) depend on these fibers.
-
Bolus Control: Narrowing helps position food between teeth during chewing.
-
Swallow Initiation: By elongating and flattening the tongue, the muscle assists in moving the food bolus toward the pharynx.
-
Speech Resonance: Subtle changes in tongue cross-section influence vowel quality.
-
Oral Cleansing: Narrowing helps sweep saliva and debris toward the oropharynx for swallowing.
Types of Tumors Affecting the Transversus Linguae Muscle
-
Benign Myogenous Tumors (e.g., rhabdomyoma): Rare, slow-growing masses of striated muscle cells.
-
Fibromas: Connective tissue-derived, generally painless nodules.
-
Schwannomas: Arising from Schwann cells of intralingual nerves; may cause localized discomfort.
-
Hemangiomas/Vascular Malformations: Benign vascular lesions that can bleed if traumatized.
-
Leiomyomas: Smooth muscle tumors, extremely rare in the tongue.
-
Granular Cell Tumors: Thought to originate from Schwann cells, often yellowish.
-
Squamous Cell Carcinoma (SCC): The most common malignant tongue tumor; often arises superficially but can invade intrinsic muscles.
-
Mucoepidermoid Carcinoma: Glandular tumor that may involve minor salivary glands in the tongue septum.
-
Adenoid Cystic Carcinoma: Slow-growing but perineurally invasive malignant tumor.
-
Rhabdomyosarcoma: Aggressive malignant tumor of striated muscle, more common in children.
-
Sarcomas (e.g., fibrosarcoma): Malignant connective tissue tumors that can invade muscle fibers.
Causes and Risk Factors
-
Tobacco Use
Smoking and chewing tobacco expose tongue tissues to carcinogens (e.g., nitrosamines), damaging DNA in muscle cells over time. -
Alcohol Consumption
Chronic heavy drinking irritates mucosa and acts synergistically with tobacco to increase tumor risk. -
Human Papillomavirus (HPV)
High-risk strains (HPV-16/18) integrate into host DNA, promoting malignant transformation. -
Chronic Irritation
Rough tooth edges, ill-fitting dentures, or habitual tongue biting can trigger local inflammatory changes. -
Radiation Exposure
Previous head and neck radiotherapy increases secondary tumor risk in tongue muscles. -
Genetic Predisposition
Inherited mutations in tumor-suppressor genes (e.g., p53) heighten malignancy risk. -
Age
Risk rises after age 40, with peak incidence in the 6th–7th decades. -
Male Sex
Historically, tongue cancers occur more often in men—likely due to higher tobacco and alcohol use. -
Poor Oral Hygiene
Chronic periodontal disease causes persistent inflammation and facilitates carcinogen penetration. -
Nutritional Deficiencies
Low intake of fruits, vegetables, and antioxidants reduces cellular defense against DNA damage. -
Betel Nut Chewing
Common in some cultures, betel quid introduces alkaloids that irritate and mutate mucosal cells. -
Immunosuppression
HIV/AIDS or post-transplant immunosuppressants reduce tumor surveillance. -
Chemical Exposures
Workplace exposure to formaldehyde, polycyclic aromatic hydrocarbons, or heavy metals. -
Chronic Lichen Planus
Erosive lesions may undergo dysplastic changes in a minority of cases. -
Epstein–Barr Virus
Linked to certain head and neck cancers, though less strongly than HPV. -
Familial Cancer Syndromes
Syndromes like Li–Fraumeni predispose to soft tissue sarcomas. -
Oral Submucous Fibrosis
A fibrosis disorder from betel nut that can transform into malignancy. -
Diabetes Mellitus
Altered immune function and glycemic fluctuations may indirectly raise risk. -
Obesity
Chronic inflammation in adipose tissue can promote tumor growth. -
Chronic Ulceration
Non-healing tongue ulcers should always raise suspicion for malignant change.
Symptoms
-
Tongue Lump
A painless or tender mass within the tongue’s midline or margins. -
Ulceration
Non-healing sore on the tongue surface that persists over 2 weeks. -
Pain or Burning
Discomfort when speaking, eating spicy foods, or touching the lesion. -
Restricted Mobility
Difficulty protruding or lateral tongue movement due to mass effect. -
Speech Changes
Altered articulation (“lisping” or imprecise consonants). -
Dysphagia
Difficulty moving food bolus, especially solids, from mouth to throat. -
Bleeding
Spontaneous or trauma-induced bleeding from a vascular lesion or ulcer. -
Swelling
Generalized tongue enlargement or localized bulge. -
Numbness or Paresthesia
Altered sensation if perineural invasion occurs. -
Weight Loss
Unintended weight loss from eating difficulties. -
Otalgia
Referred ear pain from glossopharyngeal nerve involvement. -
Voice Changes
Muffled or “thick” voice when tongue shape is altered. -
Trismus
Jaw-opening limitation if nearby muscles or masticatory structures are involved. -
Lymphadenopathy
Enlarged neck lymph nodes if regional spread occurs. -
Halitosis
Persistent bad breath from ulceration or necrotic tissue. -
Difficulty Chewing
Trouble grinding food due to tongue pain or limited mobility. -
Excessive Salivation
Drooling if swallowing is impaired. -
Difficulty Swallowing Liquids
Spillage from mouth before swallowing. -
Visible Veins
Prominent blood vessels overlying vascular tumors. -
Change in Tongue Color
White, red, or mixed patches (leukoplakia, erythroplakia).
Diagnostic Tests
-
Clinical Examination
Visual and palpation assessment for masses, ulceration, or induration. -
Intraoral Photography
High-resolution images to document lesion appearance over time. -
Excisional or Incisional Biopsy
Tissue sampling for histopathological diagnosis (gold standard). -
Fine-Needle Aspiration Cytology (FNAC)
Minimally invasive sampling of smaller nodules. -
Ultrasound Imaging
Assesses lesion depth and vascularity with Doppler studies. -
Magnetic Resonance Imaging (MRI)
High-resolution soft tissue contrast to map tumor extent. -
Computed Tomography (CT) Scan
Detects bone invasion and lymph node involvement. -
Positron Emission Tomography (PET-CT)
Evaluates metabolic activity and distant metastases. -
Panendoscopy (Triple Endoscopy)
Simultaneous laryngoscopy, bronchoscopy, and esophagoscopy to rule out synchronous tumors. -
Chest X-Ray/CT
Screens for pulmonary metastasis. -
Blood Tests
Complete blood count, liver and renal function to assess overall health. -
HPV Testing
PCR or in situ hybridization for high-risk HPV strains. -
Immunohistochemistry
Subtype tumor markers (e.g., cytokeratin, S-100, desmin). -
Sentinel Lymph Node Biopsy
Detects microscopic lymphatic spread with dye or radiotracer. -
Toluidine Blue Staining
Enhances visualization of dysplastic areas during exam. -
Brush Cytology
Non-invasive cell sampling from surface lesions. -
Fluorescence Visualization
Identifies subclinical mucosal changes with blue light. -
Bone Scan
Detects osseous metastases if bone invasion suspected. -
Genetic Testing
Identifies actionable mutations (e.g., EGFR, p53). -
Nutritional Assessment
Dietitian-led evaluation of swallowing function and nutritional risk.
Non-Pharmacological Treatments
-
Wide Local Excision
Surgical removal of tumor with a safety margin (see surgeries). -
Radiation Therapy
External beam or brachytherapy to destroy tumor cells with ionizing radiation. -
Photodynamic Therapy
Light-activated drugs plus laser to target malignant cells selectively. -
Laser Ablation
CO₂ or Nd:YAG laser vaporizes superficial tumors with minimal bleeding. -
Cryotherapy
Freezing tissue with liquid nitrogen for small benign lesions. -
Speech and Swallowing Therapy
Exercises and techniques to restore tongue function post-treatment. -
Nutritional Counseling
Diet adjustments and feeding strategies to maintain weight. -
Hyperbaric Oxygen Therapy
High-pressure oxygen promotes wound healing after radiation. -
Acupuncture
Adjunct for pain control and xerostomia management. -
Physical Therapy
Tongue stretching and resistance exercises to improve mobility. -
Occupational Therapy
Adaptive tools (e.g., special utensils) for eating and speaking. -
Psychological Support
Counseling for anxiety, body image, and quality-of-life issues. -
Lymphatic Drainage Massage
Manual techniques to reduce neck swelling. -
Oral Hygiene Protocols
Chlorhexidine rinses, saline soaks to prevent secondary infection. -
Low-Level Laser Therapy
Reduces mucositis pain and inflammation post-radiation. -
Mindfulness and Relaxation
Stress reduction to support healing. -
Speech-Generating Devices
For severe dysarthria during recovery. -
Dental Evaluation
Identify and replace sharp restorations or ill-fitting appliances. -
Swallowing Maneuvers
Supraglottic swallow, Mendelsohn maneuver to improve safety. -
Nutritional Supplements
High-calorie shakes delivered orally or via feeding tube if needed. -
Electrotherapy
Neuromuscular electrical stimulation to strengthen tongue muscles. -
Saliva Substitutes
Gels or sprays to ease dry mouth. -
Guard Appliances
Custom trays to apply topical agents or protect tissues. -
Photobiomodulation
Near-infrared light to reduce inflammation and pain. -
Aquatic Therapy
Gentle tongue and jaw movements in water to reduce swelling. -
Biofeedback
Visual feedback of tongue tension to retrain movement. -
Diet Modifications
Soft, pureed diets to reduce trauma during eating. -
Cooling Packs
Topical ice to control post-biopsy pain and swelling. -
Yoga and Breathing Exercises
Enhance overall well-being and reduce muscle tension. -
Peer Support Groups
Shared experiences and coping strategies with other patients.
Drugs
-
Cisplatin
Platinum-based chemotherapy that crosslinks DNA in rapidly dividing cells. -
5-Fluorouracil (5-FU)
Antimetabolite that inhibits thymidine synthesis in tumor cells. -
Paclitaxel
Mitotic inhibitor that stabilizes microtubules, preventing cell division. -
Docetaxel
Similar to paclitaxel, used in combination regimens. -
Methotrexate
Folate antagonist interfering with DNA synthesis. -
Carboplatin
Less nephrotoxic platinum compound alternative to cisplatin. -
Cetuximab
EGFR-targeting monoclonal antibody for SCC overexpressing EGFR. -
Nimotuzumab
EGFR inhibitor with fewer dermatologic side effects. -
Bleomycin
Induces DNA strand breaks; used in some sarcomas. -
Doxorubicin
Anthracycline antibiotic causing DNA intercalation and free radical formation. -
Cyclophosphamide
Alkylating agent that crosslinks DNA. -
Vincristine
Vinca alkaloid that disrupts microtubule assembly. -
Vinblastine
Similar to vincristine with different toxicity profile. -
Pembrolizumab
PD-1 checkpoint inhibitor used in unresectable or metastatic SCC. -
Nivolumab
Another PD-1 inhibitor, improves survival in recurrent disease. -
Cetirizine (Adjunct)
Antihistamine to reduce radiation-induced mucosal irritation. -
Morphine
Opioid analgesic for moderate to severe pain control. -
Ibuprofen
NSAID for mild pain and inflammation management. -
Lidocaine Viscous
Topical anesthetic rinse to relieve ulcer pain. -
Amifostine
Radioprotective agent reducing xerostomia during radiotherapy.
Surgeries
-
Wide Local Excision
Removal of tumor with 1–2 cm margins of healthy tissue. -
Marginal Glossectomy
Excision of superficial lesions while preserving tongue bulk. -
Partial (Hemi) Glossectomy
Resection of one side of the tongue body for deeper or larger tumors. -
Total Glossectomy
Complete removal of the mobile tongue for extensive disease. -
Reconstruction with Free Flap
Microvascular tissue transfer (e.g., radial forearm flap) to restore form and function. -
Pedicled Flap Reconstruction
Local flap (e.g., submental island flap) when microvascular expertise unavailable. -
Selective Neck Dissection
Removal of lymph nodes at risk while sparing non-involved levels. -
Modified Radical Neck Dissection
Preserves one or more non-lymphatic structures (e.g., spinal accessory nerve). -
Radical Neck Dissection
En bloc removal of all cervical lymph nodes and non-lymphatic structures for extensive nodal disease. -
Laser Resection
Endoscopic CO₂ laser for precise excision with minimal bleeding.
Prevention Strategies
-
Avoid Tobacco
Quit smoking and smokeless tobacco to remove primary carcinogenic exposure. -
Limit Alcohol
Reduce or eliminate heavy drinking to lower combined risk. -
HPV Vaccination
Protects against high-risk strains linked to oropharyngeal cancers. -
Maintain Oral Hygiene
Daily brushing, flossing, and dental checkups prevent chronic inflammation. -
Regular Dental Exams
Early detection of precancerous lesions through professional screening. -
Balanced Diet
High in fruits, vegetables, and antioxidants to support cellular health. -
Avoid Betel Nut Chewing
Eliminates exposure to fibrosis- and cancer-promoting alkaloids. -
Protect Lips from UV
Use lip balm with SPF to reduce lip cancer risk. -
Manage Chronic Lesions
Monitor and biopsy persistent ulcers, leukoplakia, or lichen planus. -
Boost Immunity
Healthy lifestyle, adequate sleep, and prompt infection management.
When to See a Doctor
If you notice any lump, ulcer, or sore on your tongue that does not heal within two weeks; experience unexplained pain, bleeding, difficulty speaking or swallowing; or observe changes in tongue shape, color, or sensation, schedule an appointment with an oral surgeon, otolaryngologist (ENT specialist), or head and neck oncologist without delay.
Frequently Asked Questions
-
What is the transversus linguae muscle?
It’s an intrinsic tongue muscle whose horizontal fibers narrow and elongate the tongue for precise movements in speech and swallowing. -
Can tumors arise directly in the transversus linguae?
Yes, tumors can develop from the muscle fibers themselves or from nearby connective, vascular, or nerve tissues. -
Are most tongue tumors benign or malignant?
The majority of intrinsic tongue muscle tumors are benign, but squamous cell carcinoma is the most common malignant type. -
What increases my risk for a muscle-based tongue tumor?
Key risks include tobacco, alcohol, HPV infection, chronic irritation, and prior radiation exposure. -
How are these tumors diagnosed?
Through clinical exam, imaging (MRI/CT), and definitively by tissue biopsy. -
Is surgery always required?
Most tumors require surgical removal; the extent depends on size, location, and whether cancer is present. -
Can radiotherapy replace surgery?
Radiation may be used alone for small tumors or adjunctively post-surgery, but it rarely replaces surgery entirely for malignant lesions. -
What are complications of tongue surgery?
Possible issues include speech changes, swallowing difficulty, and altered taste, which can often be improved with therapy. -
How long is recovery after glossectomy?
Recovery ranges from weeks (partial glossectomy) to months (total glossectomy) with rehabilitation. -
Can exercises improve tongue function?
Yes. Speech and swallowing therapists teach targeted exercises that restore mobility and strength. -
What is the prognosis for malignant tumors?
Early-stage cancers (I–II) have 5-year survival rates above 70 %, while advanced stages depend on nodal involvement and metastasis. -
Are recurrences common?
Local recurrence occurs in about 20–30 % of cases; regular follow-up is crucial. -
How often should I have follow-up exams?
Typically every 3 months for the first year, then every 6 months for years 2–3, and annually thereafter. -
Is HPV-related tongue cancer more treatable?
HPV-positive tumors often respond better to therapy and have a more favorable prognosis. -
Can lifestyle changes reduce recurrence risk?
Yes—quitting tobacco and alcohol, maintaining oral hygiene, and healthy diet all help lower the chance of recurrence.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team Rxharun and reviewed by the Rx Editorial Board Members
Last Updated: April 24, 2025.
